Results 141 to 150 of about 2,101 (161)

Filgotinib, a novel JAK1-preferential inhibitor for the treatment of rheumatoid arthritis: An overview from clinical trials

Modern Rheumatology, 2022
Yoshiya Tanaka, Arthur Kavanaugh, Iain B Mcinnes   +2 more
exaly  

Efficacy and safety of filgotinib in Japanese patients with refractory rheumatoid arthritis: Subgroup analyses of a global phase 3 study (FINCH 2)

Modern Rheumatology, 2022
Tsutomu Takeuchi, Tatsuya Atsumi, Koichi Amano   +2 more
exaly  

Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial

Lancet, The, 2017
Séverine Vermeire, Xavier Hébuterne, Xavier Roblin   +2 more
exaly  

The Relative Bioavailability and Effects of Food and Acid‐Reducing Agents on Filgotinib Tablets in Healthy Subjects

Clinical Pharmacology in Drug Development, 2019
Florence Namour
exaly  

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial

Lancet, The, 2018
Philip J Mease, Laura C Coates Mb Chb, Philip S Helliwell   +2 more
exaly  

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial

Lancet, The, 2018
Désirée M Van Der Heijde, Xenofon Baraliakos, Lianne S Gensler   +2 more
exaly  

Filgotinib Induces and Maintains Ulcerative Colitis Remission

JAMA, 2021
openaire   +2 more sources

Validated LC–MS/MS method for quantitation of a selective JAK1 inhibitor, filgotinib in rat plasma, and its application to a pharmacokinetic study in rats

Biomedical Chromatography, 2020
Ramesh Mullangi
exaly  

Rheumatoide Arthritis: Filgotinib mit gutem Sicherheitsprofil

Orthopädie & Rheuma, 2021
openaire   +1 more source

Filgotinib for Crohn's disease—expanding treatment options

The Lancet, 2017
openaire   +2 more sources